GSA Capital Partners’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-49,541
Closed -$1.34M 2107
2015
Q4
$1.34M Buy
49,541
+24,106
+95% +$621K 0.07% 489
2015
Q3
$556K Sell
25,435
-38,997
-61% -$995K 0.03% 1066
2015
Q2
$1.84M Buy
64,432
+43,832
+213% +$1.28M 0.07% 430
2015
Q1
$563K Buy
20,600
+10,753
+109% +$296K 0.02% 1309
2014
Q4
$260K Buy
+9,847
New +$288K 0.02% 1342
2014
Q1
Sell
-9,672
Closed -$352K 1965
2013
Q4
$352K Buy
9,672
+1,672
+21% +$65K 0.03% 1097
2013
Q3
$311K Buy
8,000
+1,528
+24% +$61.6K 0.02% 1124
2013
Q2
$242K Buy
+6,472
New +$256K 0.03% 984

Other funds holding MR

GSA Capital Partners's MR Position: Q1 2016 in Review

GSA Capital Partners sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 49,541 shares — an estimated $1.34M sold.

GSA Capital Partners first reported a position in MR in Q2 2013 and held it in 8 quarters. The position peaked at $1.84M in Q2 2015. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • GSA Capital Partners reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • GSA Capital Partners sold 49,541 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $1.34M.
  • GSA Capital Partners first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 8 quarters.
  • GSA Capital Partners's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.84M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on GSA Capital Partners's 13F filing for Q1 2016, filed 11 May 2016.